000 00904 a2200241 4500
005 20250517160538.0
264 0 _c20181024
008 201810s 0 0 eng d
022 _a1468-330X
024 7 _a10.1136/jnnp-2017-315768
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Su-Hyun
245 0 0 _aA step forward towards personalised immunosuppressive therapy in neuromyelitis optica spectrum disorder.
_h[electronic resource]
260 _bJournal of neurology, neurosurgery, and psychiatry
_c08 2017
300 _a619 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAquaporin 4
650 0 4 _aHumans
650 0 4 _aNeuromyelitis Optica
700 1 _aKim, Ho Jin
773 0 _tJournal of neurology, neurosurgery, and psychiatry
_gvol. 88
_gno. 8
_gp. 619
856 4 0 _uhttps://doi.org/10.1136/jnnp-2017-315768
_zAvailable from publisher's website
999 _c27270625
_d27270625